Literature DB >> 28953368

Natural Products as Platforms To Overcome Antibiotic Resistance.

Sean E Rossiter1, Madison H Fletcher2, William M Wuest1.   

Abstract

Natural products have served as powerful therapeutics against pathogenic bacteria since the golden age of antibiotics of the mid-20th century. However, the increasing frequency of antibiotic-resistant infections clearly demonstrates that new antibiotics are critical for modern medicine. Because combinatorial approaches have not yielded effective drugs, we propose that the development of new antibiotics around proven natural scaffolds is the best short-term solution to the rising crisis of antibiotic resistance. We analyze herein synthetic approaches aiming to reengineer natural products into potent antibiotics. Furthermore, we discuss approaches in modulating quorum sensing and biofilm formation as a nonlethal method, as well as narrow-spectrum pathogen-specific antibiotics, which are of interest given new insights into the implications of disrupting the microbiome.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28953368      PMCID: PMC5869711          DOI: 10.1021/acs.chemrev.7b00283

Source DB:  PubMed          Journal:  Chem Rev        ISSN: 0009-2665            Impact factor:   60.622


  228 in total

Review 1.  Target-oriented and diversity-oriented organic synthesis in drug discovery.

Authors:  S L Schreiber
Journal:  Science       Date:  2000-03-17       Impact factor: 47.728

Review 2.  Efflux-mediated antimicrobial resistance.

Authors:  Keith Poole
Journal:  J Antimicrob Chemother       Date:  2005-05-24       Impact factor: 5.790

3.  Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae.

Authors:  Annie Canu; Brigitte Malbruny; Maëlle Coquemont; Todd A Davies; Peter C Appelbaum; Roland Leclercq
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

4.  Structure-Activity Relationships of a Diverse Class of Halogenated Phenazines That Targets Persistent, Antibiotic-Tolerant Bacterial Biofilms and Mycobacterium tuberculosis.

Authors:  Aaron T Garrison; Yasmeen Abouelhassan; Verrill M Norwood; Dimitris Kallifidas; Fang Bai; Minh Thu Nguyen; Melanie Rolfe; Gena M Burch; Shouguang Jin; Hendrik Luesch; Robert W Huigens
Journal:  J Med Chem       Date:  2016-04-06       Impact factor: 7.446

5.  Diversity-oriented synthesis of cyclic acyldepsipeptides leads to the discovery of a potent antibacterial agent.

Authors:  Aaron M Socha; Nicholas Y Tan; Kerry L LaPlante; Jason K Sello
Journal:  Bioorg Med Chem       Date:  2010-08-19       Impact factor: 3.641

6.  A Tryptoline Ring-Distortion Strategy Leads to Complex and Diverse Biologically Active Molecules from the Indole Alkaloid Yohimbine.

Authors:  Nicholas G Paciaroni; Ranjala Ratnayake; James H Matthews; Verrill M Norwood; Austin C Arnold; Long H Dang; Hendrik Luesch; Robert W Huigens
Journal:  Chemistry       Date:  2017-02-03       Impact factor: 5.236

Review 7.  Quorum sensing as an integral component of gene regulatory networks in Gram-negative bacteria.

Authors:  H Withers; S Swift; P Williams
Journal:  Curr Opin Microbiol       Date:  2001-04       Impact factor: 7.934

8.  The gene cluster for the biosynthesis of the glycopeptide antibiotic A40926 by nonomuraea species.

Authors:  Margherita Sosio; Sofia Stinchi; Fabrizio Beltrametti; Ameriga Lazzarini; Stefano Donadio
Journal:  Chem Biol       Date:  2003-06

Review 9.  Function-oriented synthesis, step economy, and drug design.

Authors:  Paul A Wender; Vishal A Verma; Thomas J Paxton; Thomas H Pillow
Journal:  Acc Chem Res       Date:  2007-12-27       Impact factor: 22.384

10.  Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms.

Authors:  Martin E Stryjewski; Donald R Graham; Samuel E Wilson; William O'Riordan; David Young; Arnold Lentnek; Douglas P Ross; Vance G Fowler; Alan Hopkins; H David Friedland; Steven L Barriere; Michael M Kitt; G Ralph Corey
Journal:  Clin Infect Dis       Date:  2008-06-01       Impact factor: 9.079

View more
  83 in total

1.  The Natural Product Elegaphenone Potentiates Antibiotic Effects against Pseudomonas aeruginosa.

Authors:  Weining Zhao; Ashley R Cross; Caillan Crowe-McAuliffe; Angela Weigert-Munoz; Erika E Csatary; Amy E Solinski; Joanna Krysiak; Joanna B Goldberg; Daniel N Wilson; Eva Medina; William M Wuest; Stephan A Sieber
Journal:  Angew Chem Int Ed Engl       Date:  2019-05-16       Impact factor: 15.336

2.  Activation and discovery of tsukubarubicin from Streptomyces tsukubaensis through overexpressing SARPs.

Authors:  Qing-Bin Wu; Xin-Ai Chen; Zhong-Yuan Lv; Xiao-Ying Zhang; Yu Liu; Yong-Quan Li
Journal:  Appl Microbiol Biotechnol       Date:  2021-05-22       Impact factor: 4.813

Review 3.  Opportunities for plant natural products in infection control.

Authors:  Akram M Salam; Cassandra L Quave
Journal:  Curr Opin Microbiol       Date:  2018-09-13       Impact factor: 7.934

4.  Rapid kill assessment of an N-arylated NH125 analogue against drug-resistant microorganisms.

Authors:  Yasmeen Abouelhassan; Peilan Zhang; Yousong Ding; Robert W Huigens Iii
Journal:  Medchemcomm       Date:  2019-01-29       Impact factor: 3.597

5.  Synthesis and Biological Evaluation of the Antimicrobial Natural Product Lipoxazolidinone A.

Authors:  Jonathan J Mills; Kaylib R Robinson; Troy E Zehnder; Joshua G Pierce
Journal:  Angew Chem Int Ed Engl       Date:  2018-06-10       Impact factor: 15.336

Review 6.  Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections.

Authors:  Yu-Xuan Ma; Chen-Yu Wang; Yuan-Yuan Li; Jing Li; Qian-Qian Wan; Ji-Hua Chen; Franklin R Tay; Li-Na Niu
Journal:  Adv Sci (Weinh)       Date:  2019-12-05       Impact factor: 16.806

7.  Expanded Structure-Activity Studies of Lipoxazolidinone Antibiotics.

Authors:  Kaylib R Robinson; Jonathan J Mills; Joshua G Pierce
Journal:  ACS Med Chem Lett       Date:  2019-02-28       Impact factor: 4.345

8.  Epoxy Isonitriles, A Unique Class of Antibiotics: Synthesis of Their Metabolites and Biological Investigations.

Authors:  Guillaume Ernouf; Ingrid K Wilt; Sara Zahim; William M Wuest
Journal:  Chembiochem       Date:  2018-10-31       Impact factor: 3.164

9.  Phylogeny-Guided Approach Yields Glycopeptides with Unique Action.

Authors:  Ana V Cheng; William M Wuest
Journal:  Trends Pharmacol Sci       Date:  2020-04-01       Impact factor: 14.819

10.  Synthesis of 9-Dechlorochrysophaentin A Enables Studies Revealing Bacterial Cell Wall Biosynthesis Inhibition Phenotype in B. subtilis.

Authors:  Christopher R Fullenkamp; Yen-Pang Hsu; Ellen M Quardokus; Gengxiang Zhao; Carole A Bewley; Michael VanNieuwenhze; Gary A Sulikowski
Journal:  J Am Chem Soc       Date:  2020-09-08       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.